Goldman Sachs maintains Clarivate at Neutral, lowers price target to $2.30 from $2.60

Goldman Sachs kept its Neutral rating on Clarivate but reduced its price target by 11.5% to $2.30, suggesting an 8.5% upside from the Nov 4 close of $2.12.

Original reporting
Published Nov 5, 2026, 5:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 6:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Goldman Sachs maintains Clarivate at Neutral, lowers price target to $2.30 from $2.60 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The target reduction could trigger short‑term sell‑offs and affect related ETFs holding CLV.

02

Market read

Analyst price‑target changes are a common catalyst for short‑term price moves in micro‑cap stocks.

03

What to watch

Potential upcoming contract wins or product launches that could offset the downgrade.

Relevance 6/10Novelty 6/10Timing: immediate today

Background

Clarivate provides analytics and insights to research institutions; analyst coverage influences its valuation.

Market effects

May weigh on the information services sector as peers could face similar scrutiny.

Limited to US markets where Clarivate trades.

Minimal global impact beyond sector sentiment.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity at lower valuations.

Key entities

  • Goldman Sachs

    Equity research firm issuing the target cut.

  • Clarivate

    Provider of analytics and data services.

Related articles

$CLVTMedAI 8/10

Clarivate Plc: Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced the final results of its cash tender offers for certain outstanding debt securities. The company will purchase $415M of 3.875% Senior Secured Notes due 2028 and $118M of 4.875% Senior Notes due 2029, with proration factors of 67.9% and 45.5%, respectively. The offers expired on November 10, 2026, and settlements will occur on November 13, 2026.

$CLVTMedAI 8/10

Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, November 12, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration a

$CLVTHigh

Clarivate Plc: Clarivate Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced pricing terms for its cash tender offers to purchase certain outstanding debt securities. The company is offering to buy back its 3.875% Senior Secured Notes due 2028 and 4.875% Senior Notes due 2029, with a total cap of $500 million. The 2028 Notes Total Consideration is based on a fixed spread and a reference yield, while the 2029 Notes will be purchased at $928.75 per $1,000 principal amount. The settlement date is expected to be November 13, 2026.